EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

The Role of Organoid‐Based Drug Sensitivity Testing in Clinical Cancer Therapy

Huan Yang, Yuhong Liu, Jia Li, Yulong He, Leli Zeng, Yihang Pan

Organ Medicine · 2024

DOI: 10.1002/orm2.12 ↗

At a glance

Journal article in Organ Medicine, 2024. Written by Huan Yang and 5 co-authors. 10 references. The full text is freely available (open access, CC BY 4.0).

AbstraktBibliografické údajeCiteRelated studies

Abstract (original language)

In recent years, cancer has become a significant global health burden, with rising incidence rates emphasizing the need for innovative therapeutic strategies. Among these, organoid models have emerged as transformative platforms, offering unprecedented insights into tumor biology, drug screening, and therapeutic responses. This editorial explores the evolving role of organoids in precision oncology, highlighting their potential to bridge the gap between preclinical research and personalized medicine.

Cite

APA

Yang, H., Liu, Y., Li, J., He, Y., Zeng, L., & Pan, Y. (2024). The Role of Organoid‐Based Drug Sensitivity Testing in Clinical Cancer Therapy. Organ Medicine. https://doi.org/10.1002/orm2.12

Vancouver

Yang H, Liu Y, Li J, He Y, Zeng L, Pan Y. The Role of Organoid‐Based Drug Sensitivity Testing in Clinical Cancer Therapy. Organ Medicine. 2024. doi:10.1002/orm2.12

BibTeX
@article{Yang2024,
  author = {Yang, Huan and Liu, Yuhong and Li, Jia and He, Yulong and Zeng, Leli and Pan, Yihang},
  title = {The Role of Organoid‐Based Drug Sensitivity Testing in Clinical Cancer Therapy},
  journal = {Organ Medicine},
  year = {2024},
  doi = {10.1002/orm2.12}
}
Start for free →